In urothelial carcinoma, the UCHL5 inhibitor b-AP15 increases protein polyubiquitination and endoplasmic reticulum (ER) stress, further inhibiting cancer stem cells and overcoming cisplatin resistance [30]. Here, UCHL5 is linked to urothelial carcinoma.